NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Raysight Medical

Raysight Medical

Private
ShenzhenHealthcare & Life Scienceshttps://www.raysightmed.com/

Last Round

Strategic

Jul 1, 2026

Total Funding Raised

$116.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Raysight Medical is a medical technology company that develops AI-powered and robotic solutions for the diagnosis and treatment of cardiovascular and cerebrovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

fractional flow reserveFFRcomputational fluid dynamicsCFDcoronary artery diseasemedical imaging AIsurgical roboticsmicrovascular resistanceIMRsurgical planning softwareinterventional cardiologynon-invasive diagnosticscardiovascular AImedtechdigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Raysight Medical Comparables

Compare Raysight Medical with similar companies based on industry and business-model similarity.

Raysight Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulse Medical Imaging Technology
87%
Hangzhou Artery Technology Co., Ltd.
85%
Shanghai United Imaging Healthcare
85%

Raysight Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 1, 2026
Series DMay 26, 2026
Series CAug 23, 2021
Series BJan 11, 2021
Series A ExtensionJun 5, 2020
Series A
Jan 16, 2019

Raysight Medical Investors

Notable investors and investment history

Raysight Medical investors
InvestorRounds
Tencent ExplorationSeries C, Series B
Guoke Jiahe CapitalAngel
Green River InvestmentSeries A Extension
CAS StarAngel
MPCSeries A Extension, Series C, Series B, Series A
SDIC MerchantSeries C
China Growth CapitalSeries C, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Raised $15M with participation from haihefund.

  • May 26, 2026

    $15M round closed

Raysight Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Raysight Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Raysight Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2017
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.